¼¼°èÀÇ ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ : Á¦Ç° À¯Çüº°(Àåºñ, ¼Ò¸ðǰ), ¿ëµµº°, ¿öÅ©Ç÷ο캰, ºÐÀÚ À¯Çüº° - ¿¹Ãø(-2029³â)
Single Use Bioprocessing Market Size, Share & Trends by Product (Equipment, Consumables), Application, Workflow, Molecule Type - Global Forecast to 2029
»óǰÄÚµå : 1498345
¸®¼­Ä¡»ç : MarketsandMarkets
¹ßÇàÀÏ : 2024³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 566 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 9,000 £Ü 12,472,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,500 £Ü 14,550,000
PDF (5-user License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 12,000 £Ü 16,629,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 13,500 £Ü 18,708,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. (100% ÀÚȸ»ç´Â µ¿ÀÏ ±â¾÷À¸·Î °£Áֵ˴ϴÙ.) Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå ±Ô¸ð´Â 2024³â 177¾ï ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È 14.5%ÀÇ CAGRÀ» ±â·ÏÇϸç 2029³â¿¡´Â 349¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀåÀÇ ¼ºÀåÀº CDMO¿Í CMOÀÇ Ã¤¿ë Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌµé ±â°üÀº ÀǾàǰ °³¹ß ¹× Á¦Á¶ °øÁ¤ÀÇ ¾Æ¿ô¼Ò½ÌÀ» °í·ÁÇÏ´Â ±â¾÷¿¡ Àü¹®ÀûÀÎ ¼­ºñ½º¸¦ Á¦°øÇÔÀ¸·Î½á ¹ÙÀÌ¿À Á¦¾à »ê¾÷¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ÇâÈÄ ¸î ³â µ¿¾È ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶»ç ¹üÀ§
Á¶»ç ´ë»ó ¿¬µµ 2022-2029³â
±âÁØ ¿¬µµ 2023³â
¿¹Ãø ±â°£ 2024-2029³â
´ÜÀ§ ±Ý¾×(´Þ·¯)
ºÎ¹®º° Á¦Ç°º°, ¿ëµµº°, ¿öÅ©Ç÷ο캰, ºÐÀÚ À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°
´ë»ó Áö¿ª ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

ÃÖÁ¾»ç¿ëÀÚº°·Î´Â Á¦¾à&¹ÙÀÌ¿À ±â¾÷ ºÎ¹®ÀÌ 2023³â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÀÏȸ¿ë Àåºñ´Â ¿À¿° À§Çè °¨¼Ò, Á¦Ç° ¹«°á¼º Çâ»ó, °¡µ¿ ÁßÁö ½Ã°£ ´ÜÃà, ¼¼Ã´ ºñ¿ë Àý°¨, ½Ã¼³ ¼³Ä¡ ºñ¿ë Àý°¨, Á¦Á¶ °ø°£ Ãà¼Ò, ½Ã¼³ÀÇ À¯¿¬¼º ¹× ÀûÀÀ¼º Çâ»ó µîÀÇ ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÁ¡À¸·Î ÀÎÇØ Á¦¾à ¹× ¹ÙÀÌ¿À Á¦¾à ȸ»çµéÀÌ ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì Á¦Ç°À» äÅÃÇϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì, À¯·´ µî ±âÁ¸ ½ÃÀå°ú ½ÅÈï±¹ ½ÃÀå¿¡¼­ ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì Àåºñ ¹× ¼Ò¸ðǰÀÌ ³Î¸® »ç¿ëµÇ°í ÀÖ´Â °Íµµ ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ¹Ì±¹ÀÌ °è¼Ó ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹Ì±¹Àº ¼¼°è ÃÖ´ë ¹ÙÀÌ¿ÀÀǾàǰ ½ÃÀåÀÌÀÚ ¹ÙÀÌ¿ÀÀǾàǰ ¿¬±¸ ¹× ÅõÀÚ ºÐ¾ßÀÇ ¼±µÎÁÖÀÚÀÔ´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÇコÄÉ¾î »ê¾÷¿¡¼­ ¾ÈÀüÇÏ°í °íǰÁúÀÇ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä´Â ÇâÈÄ ¸î ³â µ¿¾È Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Çѱ¹Àº ¿ì¼öÇÑ ÀÎÇÁ¶ó, Á¤ºÎ Áö¿ø ¹× ¹Î°£ ÀÚ±ÝÀÇ Á¸Àç·Î ÀÎÇØ R&D Ãø¸é¿¡¼­ ¸Å¿ì ¹ßÀüµÈ ½ÃÀåÀÔ´Ï´Ù. ÀÌ´Â Çõ½ÅÀûÀ̰í Áøº¸µÈ ¿¬±¸ ±â¼ú °³¹ß¿¡ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ Á¦¾à»çµéÀº »ý¹°ÇÐÀû Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ °³¹ß¿¡ Àû±ØÀûÀ¸·Î Âü¿©Çϰí ÀÖÀ¸¸ç, ªÀº ó¸® ½Ã°£, ³·Àº ¼³Ä¡ ºñ¿ë, ¿¡³ÊÁö È¿À²¼ºÀÌ ³ôÀº ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½ÌÀÇ È°¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ ¹Ì±¹ ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¼¼°è ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ºÐ¼®, ±â¼ú¡¤Æ¯Çã µ¿Çâ, ±ÔÁ¦ ȯ°æ, »ç·Ê ¿¬±¸, ½ÃÀå ±Ô¸ð ÃßÁ¤ ¹× ¿¹Ãø, °¢ ºÎ¹®º°¡¤Áö¿ªº°¡¤ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï »óȲ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ÁÖ¿ä ÀλçÀÌÆ®

Á¦5Àå ½ÃÀå °³¿ä

Á¦6Àå ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå : Á¦Ç°º°

Á¦7Àå ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå : ¿ëµµº°

Á¦8Àå ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå : ¿öÅ©Ç÷ο캰

Á¦9Àå ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå : ºÐÀÚ À¯Çüº°

Á¦10Àå ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦11Àå ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå : Áö¿ªº°

Á¦12Àå °æÀï »óȲ

Á¦13Àå ±â¾÷ °³¿ä

Á¦14Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global single-use bioprocessing market is projected to reach USD 34.9 billion by 2029 from USD 17.7 billion in 2024, at a CAGR of 14.5% during the forecast period of 2024 to 2029. The growth of this market can be attributed to growing adoption among CDMOs & CMOs. The growth of the single-use bioprocessing market has been significantly driven by its increasing adoption among Contract Development and Manufacturing Organizations (CDMOs) and Contract Manufacturing Organizations (CMOs). These organizations play a crucial role in the biopharmaceutical industry by offering specialized services to companies looking to outsource their drug development and manufacturing processes. This trend is expected to drive the growth of the single-use bioprocessing market in the coming years.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsBy Product, Application, Workflow, Molecule Type, And End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

"The pharmaceutical & biotechnology companies segment accounted for the largest share by end user in 2023."

In 2023, the pharmaceutical & biotechnology companies segment accounted for the largest share by end user in the global single-use bioprocessing market. Single-use equipment decreases cross-product/batch contamination risks, increases product integrity, reduces downtime, lowers cleaning costs, decreases facility setup expenses, provides a smaller manufacturing footprint, and improves facility flexibility and adaptability. These advantages drive the adoption of single-use bioprocessing products by pharmaceutical & biopharmaceutical companies. The widespread use of single-use bioprocessing equipment and consumables in established and developed markets, such as North America and Europe, has supported market growth.

"The US has continued to dominate the single-use bioprocessing market during the forecast period of 2024-2029."

The US is the world's largest biopharmaceutical market and a leader in biopharmaceutical research/investments. The demand for single-use bioprocessing products is expected to grow in the coming years, driven by the increasing focus on biopharmaceuticals, and the need for safe & high-quality products in the healthcare industry. The nation has a highly advanced market in terms of R&D due to the presence of better infrastructure, government support, and private funding. This helps develop innovative and advanced technologies for research. Pharmaceutical companies in the US are actively participating in the development of biologics and biosimilars and increasingly utilizing single-use bioprocessing, which offers less turnaround time, has low installation costs, and is energy-efficient. These factors are supporting the growth of the single-use bioprocessing market in the country.

The primary interviews conducted for this report can be categorized as follows:

List of Companies Profiled in the Report:

Merck KGaA (Germany)

Sartorius AG (Germany)

Danaher Corporation (US)

Thermo Fisher Scientific, Inc. (US)

Merck KGaA (Germany)

Avantor, Inc. (US)

3M Company (US)

Repligen Corporation (US)

Entegris (US)

Getinge AB (Sweden)

Parker Hannifin Corporation (US)

Alfa Laval Corporate AB (Sweden)

Saint-Gobain (France)

Eppendorf SE (Germany)

Corning Incorporated (US)

Eaton Corporation plc (Ireland)

METTLER TOLEDO (US)

Porvair PLC (UK)

Lonza (Switzerland)

ABEC, INC. (US)

NewAge Industries (US)

PBS Biotech, Inc. (US)

Sentinel Process Systems, Inc. (US)

Meissner Filtration Products, Inc. (US)

SATAKE MultiMix Corporation (Japan)

Hamilton Company (US)

Membrane Solutions (US)

Cole-Parmer Instrument Company, LLC (US)

Distek, Inc. (US)

Esco Lifesciences Group Ltd. (US)

TECNIC Bioprocess solutions (Spain).

Research Coverage:

This research report categorizes the single-use bioprocessing market by product (equipment and consumables), by application (cell culture, filtration, purification, mixing, storage & transfer, and other applications), by workflow (upstream and downstream bioprocessing), by molecule type (monoclonal antibodies (mAbs), vaccines, therapeutic proteins & peptides, and cell & gene therapies), by end user (pharmaceutical & biotechnology companies, CMOs & CROs, and academic & research institutes) and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the single-use bioprocessing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the single-use bioprocessing market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall single-use bioprocessing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT

7 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION

8 SINGLE-USE BIOPROCESSING MARKET, BY WORKFLOW

9 SINGLE-USE BIOPROCESSING MARKET, BY MOLECULE TYPE

10 SINGLE-USE BIOPROCESSING MARKET, BY END USER

11 SINGLE-USE BIOPROCESSING MARKET, BY REGION

12 COMPETITIVE LANDSCAPE

13 COMPANY PROFILES

14 APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â